| Primary |
| Product Used For Unknown Indication |
56.0% |
| Schizophrenia |
9.3% |
| Bipolar Disorder |
7.8% |
| Drug Use For Unknown Indication |
4.7% |
| Psychotic Disorder |
3.1% |
| Schizophrenia, Paranoid Type |
3.1% |
| Major Depression |
2.6% |
| Mental Disorder |
2.6% |
| Bipolar I Disorder |
1.6% |
| Borderline Personality Disorder |
1.0% |
| Dementia Alzheimer's Type |
1.0% |
| Depression |
1.0% |
| Erysipelas |
1.0% |
| Hypomania |
1.0% |
| Intentional Self-injury |
1.0% |
| Paranoid Psychosis |
1.0% |
| Adjustment Disorder |
0.5% |
| Affective Disorder |
0.5% |
| Anorexia Nervosa |
0.5% |
| Exposure During Pregnancy |
0.5% |
|
| Somnolence |
10.3% |
| Psychotic Disorder |
8.6% |
| Drug Ineffective |
6.9% |
| Hyponatraemia |
5.2% |
| Parkinsonism |
5.2% |
| Sopor |
5.2% |
| Therapeutic Response Unexpected With Drug Substitution |
5.2% |
| Toxicity To Various Agents |
5.2% |
| Tremor |
5.2% |
| Ventricular Tachyarrhythmia |
5.2% |
| Weight Decreased |
5.2% |
| Weight Increased |
5.2% |
| Delirium |
3.4% |
| Intentional Overdose |
3.4% |
| Mania |
3.4% |
| Myalgia |
3.4% |
| Neuroleptic Malignant Syndrome |
3.4% |
| Psychiatric Decompensation |
3.4% |
| Psychomotor Hyperactivity |
3.4% |
| Respiratory Distress |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
41.5% |
| Schizophrenia, Paranoid Type |
11.9% |
| Schizoaffective Disorder |
11.1% |
| Schizophrenia |
5.2% |
| Drug Use For Unknown Indication |
4.4% |
| Psychotherapy |
4.4% |
| Postpartum Depression |
3.0% |
| Affective Disorder |
2.2% |
| Drug Use For Unknown Indication |
1.5% |
| Bipolar Disorder |
1.5% |
| Depression |
1.5% |
| Drug Dependence |
1.5% |
| Infection |
1.5% |
| Insomnia |
1.5% |
| Major Depression |
1.5% |
| Nausea |
1.5% |
| Psychosis |
1.5% |
| Psychotic Disorder |
1.5% |
| Bipolar Disorder |
0.7% |
| Compulsions |
0.7% |
|
| Toxicity To Various Agents |
32.4% |
| Weight Increased |
8.1% |
| Psychotic Disorder |
5.4% |
| Respiratory Arrest |
5.4% |
| Tremor |
5.4% |
| Vomiting |
5.4% |
| Disease Progression |
2.7% |
| Drug Abuse |
2.7% |
| Exposure Via Ingestion |
2.7% |
| Extrapyramidal Disorder |
2.7% |
| Hallucination, Auditory |
2.7% |
| Maternal Drugs Affecting Foetus |
2.7% |
| Neutropenia |
2.7% |
| Off Label Use |
2.7% |
| Poisoning |
2.7% |
| Psychomotor Hyperactivity |
2.7% |
| Pulmonary Embolism |
2.7% |
| Renal Failure Acute |
2.7% |
| Single Functional Kidney |
2.7% |
| Somnolence |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.6% |
| Product Used For Unknown Indication |
19.6% |
| Bipolar Disorder |
12.5% |
| Depression |
10.7% |
| Schizoaffective Disorder |
5.4% |
| Blood Cholesterol Increased |
3.6% |
| Chronic Hepatitis C |
3.6% |
| Prophylaxis |
3.6% |
| Depressive Disorder |
1.8% |
| Acute Myeloid Leukaemia |
1.8% |
| Anticoagulant Therapy |
1.8% |
| Anxiety |
1.8% |
| Catatonic Schizophrenia |
1.8% |
| Convulsion |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hypertension |
1.8% |
| Intentional Overdose |
1.8% |
| Major Depression |
1.8% |
| Ovarian Epithelial Cancer |
1.8% |
| Pain |
1.8% |
|
| Unresponsive To Stimuli |
15.6% |
| Glomerular Filtration Rate Decreased |
9.4% |
| Weight Increased |
9.4% |
| Decreased Appetite |
6.3% |
| Rectal Haemorrhage |
6.3% |
| Subarachnoid Haemorrhage |
6.3% |
| Tachycardia |
6.3% |
| Cardiac Failure |
3.1% |
| Depression |
3.1% |
| Dermatitis Allergic |
3.1% |
| Dyslipidaemia |
3.1% |
| Exposure During Pregnancy |
3.1% |
| Hyponatraemia |
3.1% |
| Hypothermia |
3.1% |
| Off Label Use |
3.1% |
| Ovarian Epithelial Cancer |
3.1% |
| Persecutory Delusion |
3.1% |
| Platelet Count Decreased |
3.1% |
| Rash |
3.1% |
| Renal Failure Acute |
3.1% |
|
